Regen Biopharma Stock Price on November 14, 2023
| RGBPP Stock | USD 0.08 0.02 19.60% |
If you're considering investing in Regen Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Regen BioPharma stands at 0.08, as last reported on the 29th of November, with the highest price reaching 0.15 and the lowest price hitting 0.03 during the day. Regen BioPharma is out of control given 3 months investment horizon. Regen BioPharma maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 6.12% are justified by taking the suggested risk. Use Regen BioPharma Risk Adjusted Performance of 0.1259, coefficient of variation of 660.11, and Semi Deviation of 23.0 to evaluate company specific risk that cannot be diversified away.
Regen Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Regen |
Sharpe Ratio = 0.1283
| Best Portfolio | Best Equity | RGBPP | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 47.69 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Regen BioPharma is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regen BioPharma by adding it to a well-diversified portfolio.
Regen BioPharma Valuation on November 14, 2023
It is possible to determine the worth of Regen BioPharma on a given historical date. On November 14, 2023 Regen was worth 1.08 at the beginning of the trading date compared to the closed value of 1.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Regen BioPharma pink sheet. Still, in general, we apply an absolute valuation method to find Regen BioPharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regen BioPharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Regen BioPharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.97 | 0.97 | 0.97 | 0.97 | 99.00 | |
11/14/2023 | 1.08 | 1.08 | 1.08 | 1.08 | 360.00 |
| 1.08 | 1.08 | 1.08 | 1.08 | 63.00 |
| Backtest Regen BioPharma | | | Regen BioPharma History | | | Regen BioPharma Valuation | Previous | Next |
Regen BioPharma Trading Date Momentum on November 14, 2023
| On November 15 2023 Regen BioPharma was traded for 1.08 at the closing time. The highest daily price throughout the period was 1.08 and the lowest price was 1.08 . The daily volume was 63.0. The net trading volume on 11/15/2023 did not cause price change. The trading delta at closing time to current closing price is 0.93% . |
Regen BioPharma Fundamentals Correlations and Trends
By evaluating Regen BioPharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Regen BioPharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Regen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Regen BioPharma Pink Sheet history
Regen BioPharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regen BioPharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regen BioPharma stock prices may prove useful in developing a viable investing in Regen BioPharma
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California. Regen Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Regen BioPharma Pink Sheet Technical Analysis
Regen BioPharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Regen BioPharma Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Regen BioPharma cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Regen BioPharma November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Regen BioPharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regen BioPharma shares will generate the highest return on investment. By undertsting and applying Regen BioPharma pink sheet market strength indicators, traders can identify Regen BioPharma entry and exit signals to maximize returns
Regen BioPharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Regen BioPharma's price direction in advance. Along with the technical and fundamental analysis of Regen Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1259 | |||
| Jensen Alpha | 6.26 | |||
| Total Risk Alpha | 0.0336 | |||
| Sortino Ratio | 0.21 | |||
| Treynor Ratio | 0.9432 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Regen Pink Sheet Analysis
When running Regen BioPharma's price analysis, check to measure Regen BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regen BioPharma is operating at the current time. Most of Regen BioPharma's value examination focuses on studying past and present price action to predict the probability of Regen BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regen BioPharma's price. Additionally, you may evaluate how the addition of Regen BioPharma to your portfolios can decrease your overall portfolio volatility.